MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR - sprookjes - yvandenbroek - TriplyDB

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR

http://www.wikidata.org/entity/Q35850389

about

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions Molecular Testing of Brain Tumor.Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations.Genome-wide methylation analyses in glioblastoma multiforme.HMGA2 expression pattern and TERT mutations in tumors of the vulva MGMT testing allows for personalised therapy in the temozolomide era.DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade.The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma.O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.A novel truncated form of HMGA2 in tumors of the ovaries.Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients.MGMT testing for glioma in clinical laboratories: discordance with methylation analyses prevents the implementation of routine immunohistochemistry.Assessing MGMT methylation status and its current impact on treatment in glioblastoma.DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation.Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.Experimental factors affecting the robustness of DNA methylation analysis.Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma.Protein sensing in living cells by molecular rotor-based fluorescence-switchable chemical probes The methylation of a panel of genes differentiates low-grade from high-grade gliomas.Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma.MGMT promoter methylation in non-neoplastic brain.Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma.A Simplified Overview of World Health Organization Classification Update of Central Nervous System Tumors 2016.Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.Prognosis of glioblastoma with faint MGMT methylation-specific PCR product.Details matter: the role of genomic location and assay standardization in DNA methylation analyses.Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma.Pyrosequencing Analysis of Promoter Methylation in Meningioma

P2860

Q26795767-E7A8BB51-811D-48C9-8C7A-DEA105B96A83 Q33729693-9B4CCEFF-26DD-4F46-BA61-7A29ACC865C5 Q34478948-2E77654A-92C7-475E-AA4F-AE0E701A24B2 Q34625644-53EFDF2A-408F-4AA5-9937-409E42ED4D17 Q35107175-261DD0EC-08B1-4650-ACB5-916916B37758 Q35605755-B236FF0B-D78F-4E83-A0A4-1C3E9F3C1B2A Q35827916-E26A647A-DFEF-406F-9984-D27E897B842F Q35946963-090DCD00-3128-4FD9-8E84-D8D2F8FE328A Q35992345-5B9428AC-929F-469F-831C-590DFFFA5429 Q36288503-C54332BF-C419-4DBF-8E82-33BBCFED9AF6 Q36500074-53C4AA88-3227-458C-B984-30263A3E3798 Q37106836-797B36E9-8263-4C98-97ED-14E5900D777A Q37526270-71877E16-127F-45CC-8D41-C4FB1719C6A1 Q38044236-DB7E070F-34CE-4BF0-9578-F95EBEEA4A70 Q38317424-89DFBFFF-ADFB-438C-AA63-5342D906E918 Q38642046-2C677D88-BC9A-4927-B338-5544BE007D55 Q38675705-CAA47BE7-2B16-4BAB-A174-D62FA0E18BAE Q38743551-5AAC14F6-086C-49D3-864F-3C8F1784C103 Q39876681-1E8D7EF4-AEBD-4F82-AC9D-17DDB72F44A7 Q41045107-85D1C509-4965-4878-BED8-F47EDA9126A5 Q41618968-47817835-9317-41D1-B8A6-5410EAFC021D Q41870675-C8321DD3-E7FE-4F22-B348-A0EA772BFCEE Q44440342-6FFC6F22-FC94-40CF-9A5D-5802E2C06CE3 Q47110506-318D91AF-DA9F-4304-A045-AEF70D64C06E Q47160563-6C106A7F-0F6B-497B-AA0A-5C647864744A Q47804454-AA76B606-3C85-4657-BAF9-A424BD3E7BDE Q48137109-DA2B93D2-5A74-4FEF-AD07-E146DC94A05A Q50434839-1449C688-C1B5-4CBE-B236-087195F1C36B Q55451515-A62B9827-29D8-4D29-9BD1-202DDCB18A42 Q58766022-FCDEAA71-D2EF-48E3-AF1C-43499EC5ED55

P2860

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR

http://www.wikidata.org/entity/Q35850389

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

MGMT promoter methylation in g ...... ative methylation-specific PCR

@ast

MGMT promoter methylation in g ...... ative methylation-specific PCR

@en

type

label

MGMT promoter methylation in g ...... ative methylation-specific PCR

@ast

MGMT promoter methylation in g ...... ative methylation-specific PCR

@en

prefLabel

MGMT promoter methylation in g ...... ative methylation-specific PCR

@ast

MGMT promoter methylation in g ...... ative methylation-specific PCR

@en

P1433

Q35850389-810B1B5A-6E65-4188-B6BC-899200D650E3

P1476

Q35850389-7567908F-C4F8-458F-A5B1-9958A120877B

P2093

Q35850389-09EB2185-B1F1-481A-B80E-72098DEFAFAC

Q35850389-263C4F02-0F54-411F-A0A2-5A148EC256D5

Q35850389-2A807613-8D8C-40F2-8023-49095B8108BE

Q35850389-4B14D6F5-AF5E-4BD0-8035-0DE7E6971CD7

Q35850389-54DA36BF-77C6-4D5A-8A2F-C661936D15F3

Q35850389-A37DAD51-20A2-4CF1-BD80-0741FF9EB5F9

Q35850389-B035520B-E14D-4EE2-A48E-2FBDB8AF0919

P2860

Q35850389-0D69FFDA-71D1-4B93-874A-AFA1A03A7F3B

Q35850389-12611E14-DC9B-4B5B-B47A-47B7A7215EE0

Q35850389-1476260F-D5E6-4250-897C-8B5A91FD8835

Q35850389-158ACAF4-3D33-438B-AF75-92A294E1CF6A

Q35850389-16CE5A9F-09D4-4903-82FF-340CA464A5C6

Q35850389-1708E8EC-1248-41B4-8536-A6C233A9F31D

Q35850389-19C56956-7E22-4E1E-A64F-B7FF652F9F99

Q35850389-19FB7BF8-EC31-4BE3-951F-29D52F83D492

Q35850389-1BA12D93-854B-491E-B6F8-A61D36D07F81

Q35850389-1E254516-B65C-48FD-84C6-5B3476C20F28

P2888

Q35850389-15F4AE2B-733E-4742-97EE-B08C6A3DB604

P304

Q35850389-C57D95C4-8236-4632-A6D5-386C4F1FA14B

P31

Q35850389-B858DC51-8624-4039-B0D4-AE1D22959370

P356

Q35850389-03BAE214-D564-4FDB-8B42-F079BD1E487E

P478

Q35850389-EF2F0E9F-5E17-4B63-A30A-406F8B46215F

P50

Q35850389-104D0DAE-1C18-4BB4-A878-79DB60F1A7AA

Q35850389-783BFE3A-91D6-4865-B94F-890CD36B3820

Q35850389-AFACA08D-E462-4B4A-B4B8-B3C760E053D0

Q35850389-B6A250D8-1767-45D7-A3CA-1E98147F752D

P577

Q35850389-C4A612AE-4BA7-4ACC-9C6B-7FDFC46086E0

P5875

Q35850389-ADDCF2FD-208E-42E3-A9C3-413C5EBD32EC

P6179

Q35850389-3AD5DF02-CE64-4820-B04B-BE875DD00548

P698

Q35850389-3AA0BC23-7865-441F-AA48-1304A03D8130

P932

Q35850389-BCF5C672-FAA4-4A94-A072-E3DFCADA4BB6

P356

1479-5876-10-36

P1433

Journal of Translational Medicine

P1476

MGMT promoter methylation in g ...... ative methylation-specific PCR

@en

P2093

Annette Bentsen Håvik

http://www.w3.org/2001/XMLSchema#string

David Scheie

http://www.w3.org/2001/XMLSchema#string

Guro Elisabeth Lind

http://www.w3.org/2001/XMLSchema#string

Hanne-Sofie Spenning Dahlback

http://www.w3.org/2001/XMLSchema#string

Hilde Honne

http://www.w3.org/2001/XMLSchema#string

Merete Hektoen

http://www.w3.org/2001/XMLSchema#string

Petter Brandal

http://www.w3.org/2001/XMLSchema#string

P2860

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference

O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The 2007 WHO classification of tumours of the central nervous system

Analysis of repetitive element DNA methylation by MethyLight.

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.

P2888

1479-5876-10-36

P304

36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-10-36

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Ragnhild A. Lothe

Torstein R. Meling

P577

2012-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221888090

http://www.w3.org/2001/XMLSchema#string

P6179

1022264975

http://www.w3.org/2001/XMLSchema#string

P698

22390413

http://www.w3.org/2001/XMLSchema#string

P932

3311573

http://www.w3.org/2001/XMLSchema#string